Dendritic cells (DCs) are a complex network of specialised antigen-presenting cells that are
critical initiators of adaptive immunity. Targeting antigen directly to DCs in situ is a …

Dendritic cells are central to the development of immunity, as they are specialized in
initiating antigen-specific immune responses. In this review, we briefly present the existing …

High-risk Human papillomavirus (HPV) infections represent an important public health issue.
Nearly all cervical malignancies are associated with HPV, and a range of other female and …

Deeper knowledge about the role of the tumor microenvironment (TME) in cancer
development and progression has resulted in new strategies such as gene-based cancer …

Cancer vaccines, a burgeoning strategy in cancer treatment, are exploring innovative
administration routes to enhance patient and medical staff experiences, as well as …

Human papillomavirus (HPV) contributes to sexually transmitted infection, which is primarily
associated with pre-cancerous and cancerous lesions in both men and women and is …

Dendritic cell (DC)-targeted vaccination is a new mode of antigen delivery that relies on the
use of monoclonal antibodies (mAb) to target antigen to specific DC subsets. The neonatal …

Vaccinations are essential for preventing and treating disease, especially cancer
nanovaccines, which have gained considerable interest recently for their strong anti-tumor …

Subunit vaccines are an important platform for controlling current and emerging infectious
diseases. The lymph nodes are the primary site generating the humoral response and …

Human papillomavirus (HPV)-induced oropharyngeal cancer now exceeds HPV-induced
cervical cancer, with a noticeable sex bias. Although it is well established that women have …